Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials

NCT05038826 is registered in ClinicalTrials.gov with Median Technologies as lead sponsor.

NCT NCT05038826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05038826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials
Lead sponsor
Median Technologies
Phase
Observational
Overall status
Completed
Start date
February 1, 2021
Completion date
December 1, 2021
Enrollment
1,833 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer